Experienced in Vasculitis

Michael W. Kreuter

Mainz, RP, DE 
Experienced in Vasculitis
Mainz, RP, DE 
OverviewLocationsClinical Research

Overview

Michael Kreuter practices in Mainz, Germany. Mr. Kreuter is rated as an Experienced expert by MediFind in the treatment of Vasculitis. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Lung Transplant, and Endoscopy.

His clinical research consists of co-authoring 330 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Vasculitis.

Gender
Male

Locations

Mainz, RP, Germany
Other Locations
Heidelberg, BW, Germany
Ludwigsburg, BW, Germany
Marburg An Der Lahn, HE, Germany
Germany
Giessen, HE, Germany
Munich, BY, Germany
Grosshansdorf, SH, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug, Other
Study Drug: ND-L02-s0201
Study Phase: Phase 2
A Randomised, Double-blind, Placebo-controlled Multicentre Clinical Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis Patients
A Randomised, Double-blind, Placebo-controlled Multicentre Clinical Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis Patients
Enrollment Status: Completed
Publish Date: April 12, 2023
Intervention Type: Drug, Device
Study Phase: Phase 2
Investigating Significant Health Trends in IPF (INSIGHTS-IPF). Nationwide Prospective Registry.
Investigating Significant Health Trends in IPF (INSIGHTS-IPF). Nationwide Prospective Registry.
Enrollment Status: Completed
Publish Date: July 27, 2022
Effectiveness of Yoga in Patients With Fibrosing Interstitial Lung Diseases - a Feasibilty and Pilot Study
Effectiveness of Yoga in Patients With Fibrosing Interstitial Lung Diseases - a Feasibilty and Pilot Study
Enrollment Status: Completed
Publish Date: December 07, 2020
Intervention Type: Other
Study Phase: Not Applicable
View 3 Less Clinical Trials

330 Total Publications

ILA or ILD in CTD: The Alphabet Soup Continues.
ILA or ILD in CTD: The Alphabet Soup Continues.
Journal: American journal of respiratory and critical care medicine
Published: October 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kreuter's expertise for a condition
ConditionClose
View All 24 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile